Department of Microbiology, University of Georgia, Athens, Georgia, USA.
mBio. 2022 Feb 22;13(1):e0269721. doi: 10.1128/mbio.02697-21. Epub 2022 Jan 11.
Cobamides are cobalt-containing cyclic tetrapyrroles involved in the metabolism of organisms from all domains of life but produced only by some bacteria and archaea. The pathway is thought to involve up to 30 enzymes, five of which comprise the so-called "late" steps of cobamide biosynthesis. Two of these reactions activate the corrin ring, one activates the nucleobase, a fourth one condenses activated precursors, and a phosphatase yields the final product of the pathway. The penultimate step is catalyzed by a polytopic integral membrane protein, namely, the cobamide (5'-phosphate) synthase, also known as cobamide synthase. At present, the reason for the association of all putative and bona fide cobamide synthases to cell membranes is unclear and intriguing. Here, we show that, in Escherichia coli, elevated levels of cobamide synthase kill the cell by dissipating the proton motive force and compromising membrane stability. We also show that overproduction of the phosphatase that catalyzes the last step of the pathway or phage shock protein A prevents cell death when the gene encoding cobamide synthase is overexpressed. We propose that in E. coli, and probably all cobamide producers, cobamide synthase anchors a multienzyme complex responsible for the assembly of vitamin B and other cobamides. E. coli is the best-studied prokaryote, and some strains of this bacterium are human pathogens. We show that when the level of the enzyme that catalyzes the penultimate step of vitamin B biosynthesis is elevated, the viability of E. coli decreases. These findings are of broad significance because the enzyme alluded to is an integral membrane protein in all cobamide-producing bacteria, many of which are human pathogens. Our results may provide new avenues for the development of antimicrobials, because none of the enzymes involved in vitamin B biosynthesis are present in mammalian cells.
钴胺素是一类含钴的环状四吡咯化合物,参与所有生命领域生物的代谢,但仅由某些细菌和古菌产生。该途径被认为涉及多达 30 种酶,其中 5 种酶构成所谓的钴胺素生物合成“后期”步骤。其中两个反应激活了 corrin 环,一个激活了核碱基,第四个反应缩合了激活的前体,而磷酸酶则产生途径的最终产物。倒数第二步由一种多跨膜整合蛋白催化,即钴胺素(5′-磷酸)合酶,也称为钴胺素合酶。目前,所有假定的和真正的钴胺素合酶与细胞膜相关联的原因尚不清楚,这令人感到好奇。在这里,我们表明,在大肠杆菌中,钴胺素合酶水平的升高通过耗散质子动力和破坏膜稳定性而杀死细胞。我们还表明,当编码钴胺素合酶的基因过表达时,催化途径最后一步的磷酸酶或噬菌体休克蛋白 A 的过表达可以防止细胞死亡。我们提出,在大肠杆菌中,可能在所有产生钴胺素的细菌中,钴胺素合酶锚定了一个负责组装维生素 B 和其他钴胺素的多酶复合物。大肠杆菌是研究最充分的原核生物,这种细菌的一些菌株是人类病原体。我们表明,当维生素 B 生物合成的倒数第二步的酶的水平升高时,大肠杆菌的生存能力下降。这些发现具有广泛的意义,因为所涉及的酶是所有产生钴胺素的细菌中的一种整合膜蛋白,其中许多是人类病原体。我们的结果可能为开发抗菌药物提供新途径,因为维生素 B 生物合成中涉及的酶都不存在于哺乳动物细胞中。